肾小球高滤过预测1型和2型糖尿病患者肾功能下降与死亡:一项21年纵向研究
该研究回顾性分析314例长期1型或2型糖尿病患者21年纵向数据,基于99mTc-DTPA动态肾显像测定的mGFR年龄性别特异性分布定义高滤过。中位21.0年随访中,高mGFR组主要复合结局风险显著高于正常mGFR组(HR 2.09),肾脏特异性复合结局风险亦显著升高(HR 4.95)。结论认为高滤过与低滤过相似,增加肾功能恶化和心肾死亡复合风险,鼓励积极筛查以优化风险分层和治疗。
要点
- 高mGFR组主要复合结局发生率为39.7%,正常mGFR组为24.5%。
- 高mGFR组主要复合结局风险较正常mGFR组升高(HR 2.09,95%CI 1.25-3.49)。
- 高mGFR组肾脏特异性复合结局风险较正常mGFR组升高(HR 4.95,95%CI 2.21-11.09)。
核心结论
- 肾小球高滤过与低滤过相似,增加糖尿病患者肾功能恶化及心血管或肾脏原因死亡的复合风险。
- 这些发现鼓励对这类患者进行积极筛查,以优化亚临床肾脏病的风险分层和治疗。
研究设计与样本
- 回顾性分析314例长期1型或2型糖尿病患者的21年纵向数据。
- 基于99mTc-DTPA动态肾显像测定的肾小球滤过率(mGFR)的年龄和性别特异性分布定义肾小球高滤过。
- 主要结局为血清肌酐翻倍、终末期肾病(ESKD)或心肾死亡的复合终点。
- 肾脏特异性结局为血清肌酐翻倍、ESKD或肾脏死亡的复合终点。
主要发现
- 中位随访21.0年,主要复合结局在高mGFR组(n=63)发生25例(39.7%),低mGFR组(n=63)发生24例(38.1%),正常mGFR组(n=188)发生46例(24.5%)。
- 与正常mGFR组相比,高mGFR组主要复合结局的HR为2.09(95%CI 1.25-3.49),低mGFR组为1.81(95%CI 1.05-3.16)。
- 与正常mGFR组相比,高mGFR组肾脏特异性复合结局的HR为4.95(95%CI 2.21-11.09),低mGFR组为3.81(95%CI 1.70-8.56)。
- 与正常mGFR组相比,高mGFR组血清肌酐翻倍的HR为4.86(95%CI 2.18-10.90),心肾死亡的HR为2.18(95%CI 1.24-3.83)。
- 与正常mGFR组相比,低mGFR组血清肌酐翻倍的HR为4.04(95%CI 1.77-9.20),心肾死亡的HR为2.26(95%CI 1.27-4.01)。
临床怎么用
- 作者认为这些发现鼓励对糖尿病患者进行积极筛查,以优化亚临床肾脏病的风险分层和治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the prognostic value of glomerular hyperfiltration on long-term kidney-related outcomes and mortality in patients with diabetes. RESEARCH DESIGN AND METHODS: We retrospectively analyzed 21-year longitudinal data from 314 patients with long-standing type 1 or type 2 diabetes. Glomerular hyperfiltration was identified based on the age- and sex-specific distribution of measured glomerular filtration rate (mGFR) by 99mTc-DTPA dynamic renal scintigraphy. The primary outcome was a composite of doubling of serum creatinine, end-stage kidney disease (ESKD), or cardiorenal death. The kidney-specific outcome was a composite of doubling of serum creatinine, ESKD, or renal death. RESULTS: Over a median of 21.0 years, the primary composite outcome occurred in 25 (39.7%), 24 (38.1%), and 46 (24.5%) participants with high mGFR (H-mGFR) (n = 63), low mGFR (L-mGFR) (n = 63), or normal mGFR (N-mGFR) (n = 188), respectively. Compared with N-mGFR, the hazard ratio (HR) for the primary composite outcome was 2.09 (95% CI 1.25-3.49) in H-mGFR and 1.81 (1.05-3.16) in L-mGFR. The HR for the kidney-specific composite outcome was 4.95 (2.21-11.09) in H-mGFR and 3.81 (1.70-8.56) in L-mGFR. The HRs for doubling of serum creatinine and cardiorenal death were 4.86 (2.18-10.90) and 2.18 (1.24-3.83) in H-mGFR and 4.04 (1.77-9.20) and 2.26 (1.27-4.01) in L-mGFR, respectively. CONCLUSIONS: Glomerular hyperfiltration, similar to hypofiltration, increases the combined risk of worsening kidney function and mortality from cardiovascular or renal causes in patients with diabetes. These findings encourage the active screening of these patients to optimize risk stratification and treatment of subclinical kidney disease.
引用
- Moriconi D, Sacchetta L, Chiriacò M, et al. Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study. Diabetes Care. 2023. PMID: 36787983. doi:10.2337/dc22-2003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。